ARCHIVES

Intense Therapies Better Than Lower Dose For AML

This article is from The Cancer Letter archive.

Vol. 27 No. 11 | November 26, 2004

Download PDF Visit The Full Archive

Related Articles

NCI CTEP Approved Trials For the Month of February

February 22, 2013

FDA Approves Generic Capecitabine

September 20, 2013

ICCCR Loses Support Of French, DeVita Resigns As President, Fischinger To Take Over

July 17, 1992

Professional Societies: ASCO Seeks Balance In Roles As U.S., International Society

May 23, 1997

House Appropriations by Institute

July 8, 1994

Group Chairman Present A Counter-Proposal To NCI Committee

June 12, 1998